title: MicroRNAs as putative mediators of treatment response in prostate cancer.
abstract: MicroRNAs (miRNAs) are an abundant class of noncoding RNAs that function to regulate post-transcriptional gene expression, predominantly by translational repression. In addition to their role in prostate cancer initiation and progression, recent evidence suggests that miRNAs might also participate in treatment response across a range of therapies including radiation treatment, chemotherapy and androgen suppression. The mechanism of this regulation is thought to be multifactorial and is currently poorly understood. To date, only a small number of studies have examined the functional role of miRNAs in response to prostate cancer treatment. Elucidating the role of miRNAs in treatment response following radiotherapy, chemotherapy and androgen suppression will provide new avenues of investigation for the development of novel therapies for the treatment of prostate cancer.
authors.affiliation: Prostate Molecular Oncology Research Group, Academic Unit of Clinical and Molecular Oncology, Institute of Molecular Medicine, St James' Hospital & Trinity College, University of Dublin, James's Street, Dublin 8, Ireland.
authors.forename: Fardod
authors.initials: F
authors.lastname: O'Kelly
authors.forename: Laure
authors.initials: L
authors.lastname: Marignol
authors.forename: Armelle
authors.initials: A
authors.lastname: Meunier
authors.forename: Thomas H
authors.initials: TH
authors.lastname: Lynch
authors.forename: Antoinette S
authors.initials: AS
authors.lastname: Perry
authors.forename: Donal
authors.initials: D
authors.lastname: Hollywood
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use; D000818:Animals; D015316:Genetic Therapy / Q000639:trends; D006801:Humans; D008297:Male; D035683:MicroRNAs / Q000502:physiology*; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D000726:Androgen Antagonists; D035683:MicroRNAs